PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/25597 Please be advised that this information was generated on 2015-02-06 and may be subject to change. 7 Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease C .H E R M SE N *, T. VAN DE W IEL, E. M O M M E R S, R. S A U E R W E IN a n d W. E L I N G U n iv e r s ity o f N ijm egen , D e p a rtm e n t of M e d ic a l M ic r o b io lo g y , P . O . B o x 9 1 0 1 , 6 5 0 0 H B N ijm e g e n , T h e N e th e r la n d s {Received 13 March 1996; revised 23 July 1996; accepted 23 July 1996) SUMMARY T h e role o f T - c e lls in d e v e lo p m e n t o f e x p e rim e n ta l c e re b ra l m a la r ia w a s a n a ly s e d in C 5 7 B 1 /6 J a n d C 5 7 B l / 1 0 m i c e in f e c te d w ith P la sm o d iu m berghei K 173 or P lasm odium berghei A N K A b y t r e a t m e n t w i t h a n t i - C D 4 o r a n t i - C D 8 m A b s . M ic e w e r e p ro te c te d a g a in st c e re b ra l m a la ria (C M ) w h e n a n t i - C D 4 o r a n t i - C D 8 m A b s w e r e i n j e c t e d b e f o r e o r d u r i n g in f e c tio n . E v e n in m ic e in e n d - s ta g e disease, i.e. w ith a b o d y te m p e r a t u r e b e lo w 35-5 °C , t r e a t m e n t w i t h a n t i - C D 4 o r a n t i - C D 8 a n tib o d ie s o r th e c o m b in a tio n p ro te c te d a g a in st C M , w h e r e a s c h lo r o q u in e t r e a t m e n t w a s c o m p le te ly in e ffe c tiv e in i n h i b i t i n g f u r t h e r d e v e lo p m e n t of th e c e re b ra l sy n d ro m e . K e y w o rd s : P lasm odiu m berghei , c ere b ra l m a la ria , p r o te c tio n , C D 4 , C D 8 , b l o o d - b r a i n b a r r ie r . INTRODUCTION There are a number of rodent models available for the study of the pathogenesis of experimental cerebral malaria. In these studies mice (Rest, 1982; Grau et ah 1986; Thumwood et ah 1988; Curfs et ah 1989), rats (Wright, Masemble & Bazira, 1971) and hamsters (Rest & Wright, 1979) were used in combination with different strains of P. berghei parasites, e.g. ANKA (Grau et al. 1986) or K173 (Curfs et al. 1989). In all these models an immunopathological re action is considered to be involved in the de velopment of the syndrome. Studies in rodent models showed sequestration and adherence of white blood cells to the endothelial lining of post-capillary venules in the brains in association with development of petechiae (Rest, 1982; Polder et ah 1992). In the model described by Grau et ah (1986) (P. berghei ANKA, CBA/Ca mice), CD4+ T-cells play an important role since depletion of CD4+ T~ cells prevents, and transfer of CD4+ T-cells from mice developing cerebral malaria enhances, devel opment of the cerebral syndrome. In addition, depletion of CD8+ T-cells did not prevent cerebral malaria. In mice with Murine Acquired Immuno deficiency Syndrome (MAIDS), which is character ized by abnormal functioning of CD4+ T-cells the level of protection against murine CM is significantly increased and is related to the duration of the viral infection and, hence, with the severity of CD4+ Tcell immunodeficiency (Eckwalanga et ah 1994). In the model using WM/Ms rats and P. berghei NK65 parasites (Imai & Kamiyama, 1994) cerebral malaria * C o r r e s p o n d in g a u th o r. T e l : -f 31 24 3614664, F a x : + 3 1 24 3 5 4 0 216. E - m a il: r .h e r m s e n @ m m b .a z n .n l Parasitology (1997), 114, 7-12 is prevented by CD8+ T-cell depletion, but not by CD4+ T-cell depletion. In our model (P . berghei K173, C57B1 mice) Curfs et al. (1989) confirmed a role for T-cells in the development of experimental cerebral malaria since nude mice, thymectomized mice and mice treated with an anti-T-cell serum were protected against cerebral malaria. Here, we describe the results of treatment with anti-CD4 and anti-CD8 antibodies in P. berghei ANKA- and K173-infected C57B1 mice. The results show that treatment with anti-CD4 or anti-CD8 antibodies can prevent development of experimental cerebral malaria. Moreover, even when performed shortly before expected death, i.e. in end-stage disease when body temperature has decreased to 35*5 °C or lower, depletion of CD4 or CD8 T-cells effectively prevented further development of the cerebral syndrome. MATERIALS AND METHODS M ic e C57Black/6J or C57Black/10 mice, aged 6-10 weeks, were obtained from specific pathogen-free colonies maintained at the Central Animal Facility of the University of Nijmegen. All mice were housed in plastic cages and received water and standard RMH food (Hope Farms, Woerden, The Netherlands) a d lib itu m . P a r a s ite K173 and ANKA were maintained by parasitized erythrocytes (PE) naive mice. Experimental mice P lasm odiu m berghei Copyright © 1997 Cambridge University Press P la sm o d iu m berghei weekly transfer of from infected into were infected intra- 8 C. Hermsen orni others Protection against cerebral malaria Controls 100 75 50 25 0 Tx intact Tx intact Tx intact Fig, 1. P rotection against cerebral m alaria in thym ccto m ized (T x ) versus in ta c t m ice a n d in re la tio n to tr e a tm e n t w ith a n ti-C D 4 o r a n ti-C D 8 m A bs 2 days before and 2 days after infection. C 57B 1/6J infected w ith P lasm odiu m berghei K173 ( T ) o r w ith A N K A ( # ) ; C57B1/10 infected w ith P . berghei K173 ( ■ ) . T h e n u m b e r o f m ic e p ro te c te d a g a in st C M versus the total n u m b e r of infected m ice is indicated for each ex p erim en tal g ro u p . peritoneally with 103 PE from blood of infected donor animals of the same strain. P. berghei A N K A (originally obtained from Dr B. Mons, Laboratory of Parasitology, University of Leiden, The Netherlands) is a gametocyte-producing strain which is passaged through Anopheles gambiae mosquitoes after 4 weekly blood passages. For this purpose mosquitoes are allowed to feed on mice 3 days after infection with 10 7 parasites. Blood-fed mosquitoes received an additional bloodmeal containing normal erythrocytes 5 days later and were allowed to infect mice 14 days later. Mice that show a transient hypothermia (in the majority of cases > 3 2 °C) survive this critical period but die in the third week or later after infection without any noticeable cerebral pathology, B ody temperature Body temperature was measured w ith a digital thermometer (Technoterm 1200) introduced into the rectum and read after 10 sec. Histology Thin blood films were made from tail-blood, stained with May-Griinwald and Giemsa’s solutions, and the proportion of red blood cells infected with the parasite was determined. Mice were killed by an overdose of ether and their brains were collected or they were collected postmortem. Brain tissue was fixed in Carnoy’s fluid for 4 h. Paraffin sections (5 ¡ivci) were stained with PAS/Haem atoxylin or G oldner’s trichrome stain, Sections were scored for the presence of petechiae. Detection of cerebral malaria In vivo C D 4 + or C D 8 + T-cell depletion Approximately 95 % of C57B1 mice infected with 103 P. berghei K173 (Curfs et al. 1992) or P. berghei ANK A parasites die early in the second week after infection. Approximately 1 day before death a progressive hypothermia develops which is strongly correlated with development of haemorrhages in the brains as observed by histology (Curfs et al. 1989). Rat monoclonal anti-CD4 and an ti-C D 8 antibodies were produced by hybridoma Y T S 191.1.2, EC ACC no. 87072282 and Y T S 169.4.2.1, ECACC no. 87072283 respectively. Both m Abs are of the IgG 2b isotype. Pristane-primed nude mice were injected Lp. with 3 x 106 hybridoma cells and the ascites produced was collected. After ammonium sulfate Parasitaemia Prevention of murine cerebral malaria by anti-CD4 or anti-CD8 Table 1. Effect of treatment with anti-C D 4 or a n ti-C D 8 m Abs before and during infection with P lasm odium berghei K173 parasites on development of cerebral malaria in C57B1 mice T re a tm e n t/ day(s) o f tr e a tm e n t* C o n tr o l Ig G 2 b -c o n tro lsJ - 2 /2 9 A n ti-C D 4 - 2 /2 4 6 8 8 + 10 A n ti-C D 8 - 2 /2 4 6 8 8 + 10 M ic e p ro te c te d ag ain st C M - tr e a te d m ice n (% ) 9 /7 8 f 0 /5 1 /7 12 0 14 3 9 /4 9 1 3 /3 3 /3 7 /8 5 /5 80 100 100 88 100 3 3 /3 6 f 3 /3 2 /3 5 /8 5 /5 92 100 66 63 100 # I n re la tio n to in fe c tio n at day 0. f S u m m a r iz e d d a ta f ro m P . berghei K 173 or P . berghei A N K A - in f e c te d m ic e (see F ig. 1). % I s o ty p e - m a tc h e d irre le v a n t m A b as a c o n tro l o f m A b a n t i - C D 4 o r a n t i - C D 8 tre a tm e n t. (45 %) precipitation and dialysis against H 20 , the solution was freeze-dried and stored at 4 °C until used. Aliquots were solubilized in sterile, pyrogenfree saline and used immediately. Normal and thym ectom ized mice were treated once or twice (4 days apart) by i.p. injection of 0*3 mg of either an ti-C D 4 or a n ti-C D 8 mAb. Treatment with an irrelevant isotype matched, ammonium sulfate pre cipitated rat m Ab was used in comparison to treatment with normal rat serum as another control. Both control treatments did not prevent devel opm ent of CM and did not affect parasitaemia. Therefore, both control treatments were used in the C D 4 +/ C D 8 + T -cell depletion experiments. T h e efficacy of T -cell depletion was determined in peripheral leucocytes isolated by water shock-treated peripheral blood, or in ACT-treated spleen cell suspensions from samples collected 3 days after treatment with the anti-T -cell mAbs (Hudson & Hay, 1989), Analysis of C D 4+/C D 8 + T -cell de pletion im m ediately after injection of the m Abs was com plicated by the presence of the injected mAb coating the C D 4 +/C D 8 + T -cells in the cell sus pensions, a problem that was absent when the analysis was performed 3 days after the last anti-T cell treatment, Cell suspensions were incubated in PBS containing 10 % FC S, 0’05 % sodium azide and 0-05 m g /m l of the anti-C D 4 or an ti-C D 8 m Abs for 30 min at 4 °C followed by a 30 min incubation of a 50 tim es diluted F IT C -labelled rabbit anti-rat Ig 9 (Dako) in PBS containing 40% m ouse serum and 0-05% sodium azide. After washing w ith PBS + 0’05 % sodium azide fluorescence was read m icro scopically. From the peripheral blood and the spleen respect ively 80% and 92% of C D 4+ and 62% and 79% of C D 8 'h T -cells were depleted. Treatm ent w ith either anti-C D 4 or anti-C D 8 mAbs did not change significantly the proportion of B-cells (data not shown). Protection against cerebral malaria was indepen dent of i.v. or i.p. injection of the an ti-T -cell m A bs (data not shown), and i.p. injections were used for all experiments. Thym ectom y Thym ectom y (Tx) was performed on m ice anaes thetized with chloralhydrate (4*5 % solution; 10 /¿1/g body weight). M ice were allowed to recover from surgery for a period of 2 weeks before they were used in experiments. S ta tistic a l analysis For statistical analysis the Student’s i-test (co m parison of 2 groups) and the Kruskal-W allis test (comparison of more than 2 groups) were used. P values < 0*05 were considered significant. RESULTS T he effect of treatment with anti-C D 4 or a n ti-C D 8 mAbs on development of experimental cerebral malaria was analysed in thymectomized and intact C57B1/6J and C57B1/10 mice infected with P . berghei A N K A or P. berghei K173 parasites. Fig. 1 shows that treatment with anti-C D 4 or a n d -C D 8 mAbs protected against CM, irrespective of th y mectom y in both C57B1/6J or C57B1/10 m ice infected with either P . berghei K173 or P . berghei A N K A parasites. Parasitaemia in .control mice that died of C M was approximately 5-10% with a reduction of the haematocrit of approximately 20% . N either th y mectomy, nor treatment with anti-C D 4 or a n ti-C D 8 mAbs significantly changed parasitaemia and haem atocrit during infection as compared to controls. A ll treated mice that did not die of cerebral malaria developed the same severe anaemia in the course of the infection (data not shown). T reatm ent w ith either an isotype-matched rat mAb or normal rat serum as a control for depletion of C D 4 + or C D 8 + T cells by specific rat mAbs had no effect on development of CM (Table 1 ) and did not change parasitaemia. T he data in Table 1 show that treatment w ith antiC D 4 or anti-C D 8 mAbs 2 days before and 2 days 10 C. Hermsen and others 40 o 35 0) «0 L_ CD £<u Q . 30 > oDQ "C 25 20 9 7 11 19 17 15 13 Days after infection Fig. 2. The effect on body temperature of treatment with anti-CD4 or anti-CD8 mAbs 2 days before and 2 days after Plasmodium berghei K173 infection in C57B1/6J mice. ( • ) Control mice; (O ) anti-CD4 treated mice; ( □ ) anti-CD8 treated m ice (n — 5). Table 2 . Effect of treatment with anti-CD4 and/or anti-C D 8 m Abs or chloroquine on development of cerebral malaria in C57B1/6J mice infected with Plasmodium berghei K173 parasites Infected m ice C M p ro te c te d /to ta l C M p ro te c te d m ic e increased T °C -|7 to tal T re a tm e n t* n (% ) n Saline C h lo ro q u in eJ A n ti-C D 4 A n ti-C D 8 A n ti- C D 4 + a n ti- C D 8 2 /5 2 0 /1 0 12/17 1 0 /2 0 7 /8 4 0 71 50 88 (% ) 1 /2 50 N .S . 1 1 /1 2 9 /1 0 Ip 92 90 100 * T re a tm e n t was given w hen th e b o d y te m p e ra tu re was b etw ee n 35*5 a n d 30*0 °C. f M ice w ith a statistically significant increase o f th e ir b o d y te m p e r a tu r e a t 24 h after treatm ent. X C hloroquine tre a tm e n t: 0*8 m g i.p. m o u s e /d a y . N .S ., N o survivors. after infection protected 80 % and 92 % respectively of the mice, whereas 1 2 % of the control mice were protected. Moreover, T-cell depletion during in-* fection and even when performed on day 8 , i.e. shortly before expected death as observed in non depleted controls, effectively prevented development of the fatal syndrome (Table 1). The effect on body temperature of treatment with anti-CD4 or anti-CD 8 mAbs 2 days before and 2 days after infection with P . berghei K \ 7 2 in CS7B1/6J mice was analysed in 8 independent experiments. The results of 1 representative experiment are depicted in Fig. 2. Body temperature of untreated infected mice dramatically decreased after 9 days of infection. A nti-C D 4 or an ti-C D 8 -treated m ice showed a limited decrease of their body temperature which stabilized. T he same effect on body tem perature was found when treatment with anti-C D 4 or anti~CD 8 mAbs was given as a single treatment up to day 8 of infection (results not shown). AntiC D 8 treatment 2 days before and 2 days after infection prevented development of CM as effective as C D 4+ T -cell depletion (Table 1) and no significant difference in body temperature during infection of the anti-CD4 and anti-C D 8 treated mice was found (Fig. 2). T o determine further the latest possible m om ent for effective anti-CD4 or an ti-C D 8 treatment in the 11 Prevention of murine cerebral malaria by anti-CD4 or anti-CD8 course of infection, mice were selected with a body temperature between 35*5 and 30 °C. If left untreated such infected mice died within 24 h as shown in Fig. 2. The results in Table 2 show that mice with such a hypothermia could be protected against fatal cerebral malaria by treatment with anti-CD4 and/or anti-CD8 antibodies, whereas chloroquine treatment could not save any of these mice. No relation could be found between body temperature at the moment of anti-T-cell treatment (30—35'5 °C) and protection against fatal cerebral malaria (data not shown). AntiCD4 or anti-CD8 treatment of mice with a body temperature below 30 °C never prevented death. Treatment with anti-CD4+ or anti-CD8+ mAbs in mice with end-stage disease did not protect all mice from the cerebral syndrome (Table 2). These last two observations were probably due to petechiae that already developed before treatment (Polder e t a l. 1988). Depletions that prevented further development of the cerebral syndrome also resulted in a subsequent increase in body temperature (Table 2). Overall in 93% (27/29) of the anti-T-cell treated mice body temperature increased within 24 h and prevented further development of the cerebral syndrome. DISCUSSION These studies demonstrate the importance of CD4+ and CD8+ T-cells in the pathogenesis of murine cerebral malaria (CM), and this was independent of the use of C57B1/6J or C57B1/10 mice, or infection with P . b e r g h e i K173 or P. b e r g h e i ANKA parasites. Thymectomized mice were used to prevent the influx of new T-cells after treatment with anti-T-cell mAbs, but no significant difference was found when data were compared to intact mice. Treatment with anti-T-cell mAbs did not completely eliminate all CD4+ or all CD8+ T-cells. Together these obser vations suggest that complete absence of CD4+ or CD8+ T-cells is not necessary to prevent devel opment of murine CM. Anti-CD4+ or anti-CD8+ Tcell treatment had no effect on parasitaemia and development of anaemia confirming the observations made by Grau e t a l. (1986) in another murine P. b e r g h e i CM model and by Imai & Kamiyama (1994) in a rat P. b e r g h e i NK 65 CM model. The observation that both anti-CD4+ and antiCD8+ T-cell depletion can prevent CM is in contrast to observations made previously by Grau et a l. (1986), who described a role for CD4+ but not CD8+ T-cells in development of CM in P. b e rg h e i ANKA-infected CBA mice. In contrast, Waki e t a l. (1992) and Imai & Kamiyama (1994) found a role for CD8+ but not CD4+ T-cells in preventing either early mortality or CM, respectively, in P. b e rg h e i NK65-infected rodents. A role for both CD4+ and CD8+ T-cells in development of CM in P. b e rg h e i ANKA-infected mice was noted by Weidanz and collaborators using various types of knock-out mice (personal communication). Hancock e t a l . (1994) found that treatment with anti-CD4 antibodies not only depletes CD4-positive T-cells but also CD4positive mononuclear cells; however, their possible role in CM remains to be determined. In contrast to our results Grau e t a l . (1986) found that CD8+ T-cell depletion did not prevent de velopment of CM in P. b e r g h e i ANKA-infected CBA mice. This apparent discrepancy may relate to different mouse strains used and/or a difference in the strain of P. b e r g h e i ANKA. Anti-CD4 or anti-CD8 T-cell treatment was effective even in mice with end-stage disease (body temperature between 35*5 and 30 °C). Histological analysis of brains of mice developing the cerebral syndrome showed that white blood cells adhere to the endothelial lining (Curfs e t a l. 1989; Polder e t a l . 1992) suggesting that these CD4+ and CD8+ T-cells are involved in disturbance of the endothelial lining and thereby in the functioning of the blood-brain barrier. Disturbance of the blood—brain barrier in mice developing CM was also observed by Thumwood e t a l, (1988) and Neill & Hunt (1992). They described leakage of Evans blue from the vasculature into brain parenchyma. In addition, P. b e r g h e i K173-infected mice with end-stage disease are sensitive to de velopment of folic acid-induced convulsions, while control mice are not. Treatment with anti-CD4+ or anti-CD8+ mAbs not only prevents CM but suc cessfully treated mice also recover from their sensitivity to folic acid-induced convulsions within 4 h after mAb treatment (C. Hermsen e t a l . 9 unpub lished observations). In human cerebral malaria convulsions are common (Waruiru e t a l . 1996), raising the question as to whether in human CM adherence of sequestered infected red blood cells and possibly the presence of leucocytes (Polder, 1989; Porta e t a l . 1993; Eling & Kremsner, 1994; Patnaik e t a L 1994; Eling & Sauerwein, 1995) are involved in excessive activation of endothelial cells and sub sequent disturbance of the function of the bloodbrain barrier. Chloroquine treatment could not save mice in end-stage disease while anti-CD4 or anti-CD8 treatment was still effective. This may be explained by the fact that chloroquine like most other antimalarial drugs needs more than 1 day to suppress parasitaemia effectively, whereas most of the mice in end-stage disease die within 1 day. Our data are compatible with the hypothesis that a localized inflammatory reaction involving both CD4+ and CD8+ T-cells disturbs and damages the endothelial lining of the blood-brain barrier eventu ally leading to petechiae. Our data suggest that both CD4+ and CD8+ T-cells are involved in stimulation of a downstream process of the development of the petechiae. VJ 12 C. Hermsen and others W e thank G. Poelen, T . van den Ing and Y. B ro m for skilled biotechnieal assistance. (1992). P a th o lo g y of fata l a n d resolving P lasm odiu m berghei c e re b ra l m a la ria in m ice. n e i l l , a. l . & h u n t , n . H. P arasitology 105, 1 6 5 -1 7 5 . p a t n a i k , j. k ., d a s , b . s., m i s h r a , s. k ., m o h a n t y , s ., REFERENCES CURFS, J. H. A. J ., SCHETTERS, T. P. M., HERMSEN, C. C., JERUSALEM, C. R., VAN ZON, A. A. J. C. & ELING, W. M. C. (1989). Im m unological aspects of cerebral lesions in m urine malaria. Clinical and E xperim ental Immunology 75, 136-140. CURFS, J. H. A. J., HERMSEN, C. C,, MEUWISSEN, J. H. E. TH. & e l i n g , W. M. c. (1992). Im m u n iz a tio n against cerebral pathology in Plasm odium berghei -in fected mice. Parasitology 105, 7-14. ECKWALANGA, M., MARUSSIG, M., TAVARES, M. D., s a t p a t h y , s. k . & m o h a n t y , d . (1994). V a s c u la r clogging, m o n o n u c le a r cell m ig ra tio n , a n d e n h a n c e d vascular p e rm e a b ility in th e p a th o g e n e s is o f h u m a n cereb ral m alaria. A m e ric a n J o u rn a l o f T ro p ic a l M edicin e a n d H y g ie n e 51, 6 4 2 -6 4 7 . p o l d e r , t . w . (1989), P h .D . D is s e r ta tio n : M o r p h o lo g y of cereb ral m a la ria clinical a n d e x p e rim e n ta l s tu d y . POLDER, T. W ., ELIN G , W . M ., KUBAT, K. & JERUSALEM, C. R. (1988). H is to c h e m is tr y o f c e re b ra l lesions in m ic e infected w ith P la sm o d iu m berghei . T ro p ica l M e d ic in e an d P a ra sito lo g y 39, 2 7 7 -2 8 3 . POLDER, T. w., ELIN G, W. M. C., CURFS, J. H. A. J,, BOUANGA, J. C., HULIER, E., PAVLOVITCH, J. H., JERUSALEM, C. R. & W IJERS-ROUW , M . (1992). MINOPRIO, P., PORTNOI, D., RENIA, L. & MAZIER, D. U ltr a s tr u c tu r a l c h a n g e s in th e b l o o d - b r a i n b a r r ie r o f m ice infected w ith P la sm o d iu m berghei, A c t a L eid en sia 60, 3 1 -4 6 . (1994). M u rin e A I D S p ro tects m ice against experim ental cerebral m alaria; d o w n -reg u la tio n by interleukin 10 of a T - h e lp e r type 1 C D 4 + cell-m ed iated pathology. Proceedings o f the N a tio n a l A c a d em y o f Sciences , U S A 91, 8097-8101. e l i n g , w. M. c. & k r e m s n e r , P. G. (1994). C ytokines in m alaria, pathology and p ro tectio n . B iotherapy 7, PORTA, J . } CAROTA, A., PIZZOLATA, G. P . , W IL D I, E., WIDMER, M. C ., MARGAIRRAZ, C . & GRAU, G. E. (1993), g r a u , g . e ., p i g u e t , p. f . , e n g e r s , H. D., LOUIS, J. A., Im m u n o p a th o lo g ic a l c h a n g e s in h u m a n c e re b ra l m alaria. C lin ical N eu ro p a th o lo g y 12, 1 4 2 -1 4 6 . r e s t , j. r . (1982). C e r e b r a l m a la ria in in b r e d m ice. A n ew m o d e l a n d its p a th o lo g y . T ransactions o f the R o y a l S o c ie ty o f T ro p ica l M e d ic in e an d H y g ien e 76, 4 1 0 -4 1 5 . REST, j. R. & W RIGHT, d . h . (1979). E le c tro n m ic ro s c o p y o f cerebral m a la ria in g o ld e n h a m s te r s (M esocricetu s auratus). J o u rn a l o f P a th o lo g y 127, 1 1 5 -1 2 0 . VASSALLI, P. & LAMBERT, P. H. (1986). L 3 T 4 T - THUMWOOD, C. M ., HU N T, N . H ., CLARK, I. A, & COWDEN, 211-221 . e l i n g , w. m . c. & s a u e r w e i n , r . (1995). S evere an d cerebral m alaria: co m m o n or d istin ct pathophysiology ? R eview s in M ed ica l M icrobiology 6 , 1 7 -2 5 . lym phocytes play a m ajo r role in th e path o g en esis of m u rin e cerebral m alaria. Journal o f Immunology 137, 2348-2354. HANCOCK, W. W., ADAMS, D. H., WYNER, L. R., SAYEGH, m . h . & k a r n o v s k y , M. j. (1994). C D 4 + M o n o n u c le a r cells induce cytokine expression, vascular sm o o th m uscle cell proliferation, and arterial occlusion after endothelial injury. A m erican Journal of P athology 145, 1008-1014. P ractical Im m unology . Blackwell Scientific, L o n d o n . H u d s o n , l . & h a y , f . (1 9 8 9 ). Im ai, y. & k am iyam a, T. (1994), T -ly m p h o c y te d e p e n d e n t developm ent of cerebral sy m p to m s in W M / M s rats infected w ith Plasm odium berghei. A nnals of Tropical M edicine and P arasitology 88 , 83-85. w . b . (1988). B re a k d o w n o f th e b l o o d - b r a in b a r r ie r in m u r in e c ere b ra l m a la ria . P a ra sito lo g y 96, 5 7 9 -5 8 9 . WAKI, S., UEHARA, K ., KANBE, K., ONO, K., SUZUKI, M. & NARIU-CHI, H. (1992). T h e role o f T - c e lls in p a th o g e n e sis a n d p ro te c tiv e im m u n ity to m u r i n e m alaria. Im m unology 75, 6 4 6 -6 5 1 . WARUIRI, C. M., N EW TO N , C. R. J. C., FORSTER, D ., N EW , L., WINSTANLEY, R., M W ANGI, I ., MARSH, V., WINSTANLEY, M ,, s n o w , R. w . & m a r s h , K. (1996). E p ile p tic se iz u re s a n d m alaria in K e n y a n c h ild re n . T ransaction s o f the R o y a l S o c ie ty o f T ro p ic a l M e d ic in e a n d H y g ie n e 90, 152-155. WRIGHT, D, H., MASEMBE, R. M. & BAZIRA, E. R. (1971). T h e effect of a n ti- th y m o c y te s e r u m o n g o ld e n h a m ste rs a n d ra ts in fe c te d w ith P . berghei. B r itis h J o u rn a l o f E x p e rim e n ta l P a th o lo g y 52, 4 6 5 -4 7 7 .
© Copyright 2024